Kyverna Therapeutics, Inc. Stock Forecast
Big movements in Kyverna Therapeutics, Inc. stock price on Thursday moving 11.44% between high and low
(Updated on May 02, 2024)
The Kyverna Therapeutics, Inc. stock price fell by -9.51% on the last day (Thursday, 2nd May 2024) from $16.61 to $15.03. During the last trading day the stock fluctuated 11.44% from a day low at $14.86 to a day high of $16.56. The price has fallen in 7 of the last 10 days and is down by -20.94% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -194 thousand shares and in total, 537 thousand shares were bought and sold for approximately $8.07 million.
The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $14.28 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -39.44% during the next 3 months and, with a 90% probability hold a price between $8.65 and $13.13 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
KYTX Signals & Forecast
A buy signal was issued from a pivot bottom point on Monday, April 29, 2024, and so far it has risen 0.133%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Kyverna Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $15.84 and $22.05. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Support, Risk & Stop-loss for Kyverna Therapeutics, Inc. stock
Kyverna Therapeutics, Inc. finds support from accumulated volume at $15.01 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $1.70 between high and low, or 11.44%. For the last week, the stock has had daily average volatility of 9.89%.
Kyverna Therapeutics, Inc. is oversold on RSI14 (22). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (KYTX) For The Upcoming Trading Day Of Friday 3rd
For the upcoming trading day on Friday, 3rd we expect Kyverna Therapeutics, Inc. to open at $15.48, and during the day (based on 14 day Average True Range), to move between $13.48 and $16.58, which gives a possible trading interval of +/-$1.55 (+/-10.34%) up or down from last closing price. If Kyverna Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 20.68% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $15.01 (0.13%) than the resistance at $15.47 (2.93%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Kyverna Therapeutics, Inc. stock A Buy?
Kyverna Therapeutics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.
Current score: -1.350 Sell Candidate Downgraded
Predicted Opening Price for Kyverna Therapeutics, Inc. of Friday, May 3, 2024
| Fair opening price May 3, 2024 | Current price |
|---|---|
| $15.48 ( 3.02%) | $15.03 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for KYTX
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 17.18 | 14.33 % | |
| R2 | 16.53 | 10.01 % | ||
| R1 | 16.13 | 7.34 % | ||
| Current price: | 15.03 | |||
| Support | S1 | 14.83 | -1.30 % | |
| S2 | 14.43 | -3.97 % | ||
| S3 | 13.78 | -8.29 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 16.61 | 10.51 % | |
| R2 | 15.94 | 6.05 % | ||
| R1 | 15.47 | 2.93 % | ||
| Current price | 15.03 | |||
| Support | S1 | 15.01 | -0.133% | |
| S2 | 0 | . | ||
| S3 | 0 | . |
FAQ
Click here for our free guide on how to buy Kyverna Therapeutics, Inc. Stock.
